Update on the Treatment of HER2-Low and HER2-Ultralow Metastatic Breast Cancer
In this CME activity, Review the latest advancements in human epidermal growth factor receptor 2 (HER2)-ultralow mBC by joining this in-depth discussion between leading pathology and medical oncology experts. Learn how a new drug indication as well as updated ASCO/CAP guidelines for HER2-low and -ultralow classifications will redefine the way patients with HER2 mBC are…




